Skip to main content
Clinical Trials/NCT00606827
NCT00606827
Completed
Phase 4

Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy in Patients Undergoing Coronary Angiography

Ospedale Misericordia e Dolce1 site in 1 country500 target enrollmentJanuary 2005

Overview

Phase
Phase 4
Intervention
Sodium Bicarbonate
Conditions
Contrast-Induced Nephropathy
Sponsor
Ospedale Misericordia e Dolce
Enrollment
500
Locations
1
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Contrast-induced nephrophaty (CIN) accounts for more than 10% of hospital-acquired renal failure. Hydration with sodium bicarbonate is more protective than isotonic saline in animals. Limited data are available in humans. We compared the efficacy of sodium bicarbonate versus isotonic saline to prevent CIN in a large population of patients with renal dysfunction undergoing coronary angiography or intervention.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
March 2006
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ospedale Misericordia e Dolce
Responsible Party
Principal Investigator
Principal Investigator

Mauro Maioli

MD

Ospedale Misericordia e Dolce

Eligibility Criteria

Inclusion Criteria

  • patients with creatinine clearance \< 60 mL/min

Exclusion Criteria

  • contrast medium administration within the previous 10 days
  • end-stage renal failure requiring dialysis
  • refusal to give informed consent

Arms & Interventions

A

Bicarbonate

Intervention: Sodium Bicarbonate

B

Saline

Intervention: Isotonic Saline

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials